Viewing StudyNCT06462092



Ignite Creation Date: 2024-07-17 @ 10:48 AM
Last Modification Date: 2024-10-26 @ 3:32 PM
Study NCT ID: NCT06462092
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-06-18
First Post: 2024-06-12

Brief Title: Sacituzumab Govitecan and Intrathecal Chemotherapy for Treating Leptomeningeal Metastases From Her2-negative Breast Cancer
Sponsor: Guangzhou Medical University
Organization: Guangzhou Medical University

Conditions & Keywords Data

Conditions:
Name
Leptomeningeal Metastases
Keywords:
Name View
Breast cancer View
Her2- Human Epidermal Growth Factor Receptor 2 Negative View
Leptomeningeal Metastases View
Sacituzumab Govitecan View
Pemetrexed View
Intrathecal chemotherapy View